DNA Data for Sale: 23andMe’s Potential Acquisition Raises Privacy Concerns
The company 23andMe, renowned for its genetic testing services, finds itself in a precarious situation. Its shares face the risk of being delisted, and the drug development division has recently been shut down altogether....
